DISCOVERIES 09
Micronesian women , who have low breast cancer screening rates , into the TMIST trial comparing standard 2-D mammography with 3-D tomosynthesis . In 2019 , through its affiliation with the UH Cancer Center , Family Health Plan ( FHP ) Health Center in Guam became an NCORP site making clinical trials available in that U . S . territory .
The Cancer Center relies on members of the Hawai ‘ i Cancer Consortium ( HCC ) and the greater Hawai ‘ i oncology community to provide its clinical research studies to cancer patients . HCC members include Adventist Health Castle , Hawaii Medical Service Association , Hawai ‘ i Pacific Health , Kuakini Medical Center , The Queen ’ s Health Systems , and the John A . Burns School of Medicine . In addition , our clinical trials network involves the majority of medical and radiation oncology practices on O ‘ ahu and Tripler Army Medical Center . These partnerships have made cutting-edge cancer treatments accessible to the people of Hawai ‘ i , contributed to improved patient outcomes , helped diversify clinical trials representation , and aided in the reduction of cancer disparities for all people .
POPULATION SCIENCES IN THE PACIFIC PROGRAM
CANCER EPIDEMIOLOGY
UH Cancer Center and the University of Southern California epidemiologists established the Multiethnic Cohort ( MEC ) Study in 1993 . Over the years , the study has provided many advances in understanding differences in cancer risk that exist among racial / ethnic groups , and has had significant impact identifying ways to prevent cancer .
The MEC Study , the most ethnically-diverse and long-standing longitudinal cohort study in the world , has gained national and international recognition among biomedical scientists . It has followed 215,000 residents of Hawai ‘ i and Los Angeles , age 45 to 75 since 1993 , for the development of cancer and other chronic diseases . It includes men and women of five main ethnic groups : Japanese Americans , Native Hawaiians , African Americans , Latinos , and Whites .
1993 |
Multiethnic Cohort ( MEC ) Study began by CRCH and University of Southern California ( USC ). |
1996- 1998 |
CRCH partnered with pharmaceutical company Eli Lilly to patent a drug from cryptophycins , anti-cancer compounds discovered by cancer center scientists in blue-green algae . |
1996- 1998 |
CRCH received NCI designation ( via P30 Cancer Center Support Grant ). |
1999 |
Dr . Brian Issell stepped down as Director of the Cancer Research Center of Hawai ‘ i & was succeeded by Carl-Wilhelm Vogel . MD , PhD . |